Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel digital biomarkers for...